SAGUENAY, Canada, November 2020 – CONFORMiT announces today the acquisition of the Quebec company Dilygence Apps Inc.
Since its creation, Dilygence has built a solid reputation for its SaaS solution for risk analysis management in several industries such as pulp and paper and the manufacturer. This acquisition allows CONFORMiT to expand its development team with offices in Quebec City and clients across North America.
“This is a perfect combination between our two companies. Our clients will quickly benefit from this synergy. Beyond the software, passionate humans join our team in order to continue our growth and revolutionize the world of health, safety and environmental management. We are building a large Quebec company that shines internationally.” declared Éric Desbiens, President and CEO of CONFORMiT.
The CONFORMiT software, simple, reliable and robust, intended for high-risk industries, will use Dilygence’s expertise to continue to fulfill this common objective: to improve productivity and reduce the risk of accidents.
“Joining forces with CONFORMiT in order to pursue our mission was an obvious choice. We share a common vision and complementary products. Together, we will create a unique development strength for innovative health and safety technologies.” declares Philippe Moreau, co-founder and President of Dilygence.”
CONFORMiT, along with Dilygence, reinforces its position as a trusted technological partner. Thanks to a unique vision in digital transformation and to robust features, thought out with depth, it is already providing many benefits to current and future clients. To this day, the CONFORMiT software has 500,000 active users in more than 20 countries.
CONFORMiT already has several projects to make this new development fruitful. As Éric Desbiens adds, “the effective management of health, safety and environmental risks generates a lot of productivity for our current and future clients. With this alliance, this benefit will be even greater !”
With an approximate 30% annual growth, future acquisitions are expected in the United States and Europe.